Free Trial

Salesforce (CRM) Stock Forecast & Price Target

Salesforce logo
$242.78 +9.41 (+4.03%)
Closing price 03:59 PM Eastern
Extended Trading
$242.83 +0.05 (+0.02%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Salesforce - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
2
Hold
9
Buy
31

Based on 42 Wall Street analysts who have issued ratings for Salesforce in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 42 analysts, 2 have given a sell rating, 9 have given a hold rating, 27 have given a buy rating, and 4 have given a strong buy rating for CRM.

Consensus Price Target

$347.50
43.13% Upside
According to the 42 analysts' twelve-month price targets for Salesforce, the average price target is $347.50. The highest price target for CRM is $440.00, while the lowest price target for CRM is $225.00. The average price target represents a forecasted upside of 43.13% from the current price of $242.78.
Get the Latest News and Ratings for CRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Salesforce and its competitors.

Sign Up

CRM Analyst Ratings Over Time

TypeCurrent Forecast
8/15/24 to 8/15/25
1 Month Ago
7/16/24 to 7/16/25
3 Months Ago
5/17/24 to 5/17/25
1 Year Ago
8/16/23 to 8/15/24
Strong Buy
4 Strong Buy rating(s)
4 Strong Buy rating(s)
5 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
27 Buy rating(s)
27 Buy rating(s)
32 Buy rating(s)
24 Buy rating(s)
Hold
9 Hold rating(s)
8 Hold rating(s)
5 Hold rating(s)
9 Hold rating(s)
Sell
2 Sell rating(s)
3 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$347.50$348.16$352.62$292.79
Forecasted Upside43.13% Upside35.03% Upside21.17% Upside11.38% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

CRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Salesforce Stock vs. The Competition

TypeSalesforceComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.79
2.65
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside43.13% Upside67.39% Upside11.77% Upside
News Sentiment Rating
Positive News

See Recent CRM News
Positive News
Positive News

Subscribe to MarketBeat All Access for the recommendation accuracy rating
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/15/2025DA Davidson
2 of 5 stars
Gil Luria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Neutral$225.00-3.58%
8/13/2025Stifel Nicolaus
4 of 5 stars
Parker Lane
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$375.00 ➝ $325.00+40.45%
7/14/2025Royal Bank Of Canada
3 of 5 stars
R. Jaluria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$275.00+5.68%
7/11/2025JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Patrick Walravens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$430.00+62.91%
7/10/2025Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Vanvliet
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Cautious
7/10/2025BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Keith Bachman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$350.00 ➝ $335.00+25.53%
6/18/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Keith Weiss
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set TargetOverweight ➝ Overweight$404.00+56.00%
6/10/2025Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brian Schwartz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$370.00+36.04%
6/5/2025Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
H. Engel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
5/30/2025Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Radke
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$320.00 ➝ $295.00+11.92%
5/30/2025Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Huff
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$311.00 ➝ $309.00+16.88%
5/29/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Keith Weiss
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$393.00 ➝ $404.00+46.87%
5/29/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Turrin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$255.00 ➝ $275.00+4.94%
5/29/2025Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Nehal Chokshi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$423.00 ➝ $396.00+51.50%
5/29/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Raimo Lenschow
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$425.00 ➝ $347.00+34.38%
5/29/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kash Rangan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$340.00 ➝ $385.00+47.64%
5/29/2025Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Mark Moerdler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetUnderperform ➝ Underperform$243.00 ➝ $255.00-7.30%
5/28/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brent Bracelin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$315.00 ➝ $335.00+21.53%
5/28/2025Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Hynes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$400.00 ➝ $350.00+26.39%
5/28/2025Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Scott Berg
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$400.00+44.44%
5/28/2025Westpark Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Shauger
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$320.00+15.55%
5/15/2025Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Gregg Moskowitz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$425.00 ➝ $380.00+30.85%
4/21/2025Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Difucci
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral
3/31/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brent Thill
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$425.00 ➝ $375.00+43.23%
3/20/2025Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Beynon
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$320.00 ➝ $320.00+14.67%
3/17/2025Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Verkhovski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetSector Outperform ➝ Sector Outperform$400.00 ➝ $345.00+23.43%
2/27/2025Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Yun Kim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetHold ➝ Hold$330.00 ➝ $300.00+0.80%
2/27/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Rob Oliver
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$430.00 ➝ $400.00+30.21%
2/27/2025Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brad Sills
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$440.00 ➝ $400.00+30.21%
2/19/2025Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
O. Sheikh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
1/17/2025TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Derrick Wood
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$380.00 ➝ $400.00+24.62%
12/18/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$425.00 ➝ $425.00+21.08%
12/13/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Ader
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Weight ➝ Overweight$440.00+22.84%
12/4/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$340.00 ➝ $380.00+3.28%
12/4/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$380.00 ➝ $400.00+20.57%
10/17/2024CfraAaron Siegel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target$343.00+16.88%
10/2/2024Northland Capmk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
N. Chokshi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
8/30/2024Phillip Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Accumulate$305.00+20.72%
8/29/2024FBN Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Seyrafi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/29/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Slowinski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)

Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.

This little-known company holds nearly 100 patents and trades for around $7
8/29/2024Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$335.00 ➝ $335.00+28.58%
8/29/2024Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetStrong-Buy ➝ Strong-Buy$325.00 ➝ $350.00+35.19%
8/26/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$300.00 ➝ $300.00+13.39%
5/30/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$350.00 ➝ $300.00+39.82%
4/16/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$365.00+33.82%
3/6/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$290.00 ➝ $354.00+16.46%
9/15/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$267.00+22.04%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 10:14 PM ET.


Should I Buy Salesforce Stock? CRM Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, August 12, 2025. Please send any questions or comments about these Salesforce pros and cons to contact@marketbeat.com.

Salesforce
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Salesforce, Inc.:

  • The current stock price is around $230, which is significantly lower than its 1-year high of $369, potentially offering a buying opportunity for investors looking for value.
  • Salesforce, Inc. reported strong earnings recently, with earnings per share surpassing analysts' expectations, indicating robust financial performance and growth potential.
  • The company has shown a year-over-year revenue increase of 7.6%, reflecting its ability to grow and adapt in a competitive market.
  • Salesforce, Inc. has a solid return on equity of 12.94%, suggesting effective management and profitability, which can be attractive to investors seeking reliable returns.
  • With 80.43% of its stock owned by hedge funds and institutional investors, there is a strong level of confidence in the company's future prospects from major financial players.

Salesforce
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Salesforce, Inc. for these reasons:

  • Insider selling has been notable, with the CEO recently selling a significant number of shares, which could signal a lack of confidence in the company's short-term performance.
  • The company has a relatively high price-to-earnings (P/E) ratio of 36.01, which may indicate that the stock is overvalued compared to its earnings, posing a risk for potential investors.
  • Salesforce, Inc. has a beta of 1.37, suggesting that its stock is more volatile than the market, which could lead to larger price swings and increased risk for investors.
  • The company has a debt-to-equity ratio of 0.14, which is low, but any increase in debt could impact its financial stability and investor confidence.
  • Recent trading activity shows a downward trend, with shares trading down about 0.9%, which may indicate bearish sentiment among investors.

CRM Forecast - Frequently Asked Questions

According to the research reports of 42 Wall Street equities research analysts, the average twelve-month stock price forecast for Salesforce is $347.50, with a high forecast of $440.00 and a low forecast of $225.00.

42 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Salesforce in the last year. There are currently 2 sell ratings, 9 hold ratings, 27 buy ratings and 4 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CRM shares.

According to analysts, Salesforce's stock has a predicted upside of 43.13% based on their 12-month stock forecasts.

Over the previous 90 days, Salesforce's stock had 3 downgrades and 2 upgrades by analysts.

Analysts like Salesforce more than other "computer and technology" companies. The consensus rating score for Salesforce is 2.79 while the average consensus rating score for "computer and technology" companies is 2.65. Learn more on how CRM compares to other companies.


This page (NYSE:CRM) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners